Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein 2

Circulation Journal

Volumn 68, Issue 7, 2004, Pages 691-702

  Kawai, Takao ^b   Takahashi, Tomoyuki ^a   Esaki, Masayasu ^b   Ushikoshi, Hiroaki ^b   Nagano, Satoshi ^c   Fujiwara, Hisayoshi ^b   Kosai, Ken Ichiro ^c,d  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c KURUME UNIVERSITY   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiomyogenic differentiation; Embryonic stem cell; Gene expression; Growth factors

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; RECOMBINANT GROWTH FACTOR;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EMBRYONIC STEM CELL; GENE EXPRESSION; HEART DEVELOPMENT; HEART MUSCLE CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STEM CELL;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; DNA PRIMERS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; MICE; MYOCARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 3142765398     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.691     Document Type: Article

References (43)

1. Johkura K, Cui L, Suzuki A, Teng R, Kamiyoshi A, Okamura S, et al. Survival and function of mouse embryonic stem cell-derived cardiomyocytes in ectopic transplants. Cardiovasc Res 2003; 58: 435-443.
2. Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 1996; 98: 216-224.
3. Sata M. Molecular strategies to treat vascular diseases: Circulating vascular progenitor cell as a potential target for prophylactic treatment of atherosclerosis. Circ J 2003; 67: 983-991.
4. Koh GY, Soonpaa MH, Klug MG, Pride HP, Cooper BJ, Zipes DP, et al. Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest 1995; 96: 2034-2042.
5. Koh GY, Klug MG, Soonpaa MH, Field LJ. Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest 1993; 92: 1548-1554.
6. Leor J, Patterson M, Quinones MJ, Kedes LH, Kloner RA. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat: A potential method for repair of infarcted myocardium? Circulation 1996; 94: 11-332-11-336.
7. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001; 108: 407-414.
8. Heng BC, Haider H, Sim EK, Cao T, Ng SC. Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro. Cardiovasc Res 2004; 62: 34-42.
9. Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N. From the cover: Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl AcadSci USA 2000; 97: 11307-11312.
10. Wiles MV, Keller G. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 1991; 111: 259-267.
11. Biesecker LG, Emerson SG. Interleukin-6 is a component of human umbilical cord serum and stimulates hematopoiesis in embryonic stem cells in vitro. Exp Hematol 1993; 21: 774-778.
12. Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI. Embryonic stem cells express neuronal properties in vitro. Dev Biol 1995; 168: 342-357.
13. Slager HG, Van Inzen W, Freund E, Van den Eijnden-Van Raaij AJ, Mummery CL. Transforming growth factor-beta in the early mouse embryo: Implications for the regulation of muscle formation and implantation. Dev Genet 1993; 14: 212-224.
14. Behfar A, Zingman LV, Hodgson DM, Ranzier JM, Kane GC, Terzic A, et al. Stem cell differentiation requires a paracfine pathway in the heart FASEB J 2002; 16: 1558-1566.
15. Olson EN, Srivastava D. Molecular pathways controlling heart development. Science 1996; 272: 671-676.
16. Moore CS, Mjaatvedt CH, Gearhart JD. Expression and function of activin beta A during mouse cardiac cushion tissue formation. Dev Dyn 1998; 212: 548-562.
17. Dell'Era P, Ronca R, Coco L, Nicoli S, Metra M, Presta M. Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. Circ Res 2003; 93: 414-420.
18. Choy M, Oltjen SL, Otani YS, Armstrong MT, Armstrong PB. Fibroblast growth factor-2 stimulates embryonic cardiac mesenchymal cell proliferation. Dev Dyn 1996; 206: 193-200.
19. Schultheiss TM, Burch JB, Lassar AB. A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev 1997; 11: 451-462.
20. Alsan BH, Schultheiss TM. Regulation of avian cardiogenesis by Fgf8 signaling. Development 2002; 129: 1935-1943.
21. Barron M, Gao M, Lough J. Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative. Dev Dyn 2000; 218: 383-393.
22. Lough J, Barron M, Brogley M, Sugi Y, Bolender DL, Zhu X. Combined BMP-2 and FGF-4, but neither factor alone, induces cardiogenesis in non-precardiac embryonic mesoderm. Dev Biol 1996; 178: 198-202.
23. Zhang H, Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996; 122: 2977-2986.
24. Wood SA, Allen ND, Rossant J, Auerbach A, Nagy A. Non-injection methods for the production of embryonic stem cell-embryo chimaeras. Nature 1993; 365: 87-89.
25. Boheler KR, Czyz J, Tweedie D, Yang HT, Anisimov SV, Wobus AM. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 2002; 91: 189-201.
26. Pirity M, Hadjantonakis AK, Nagy A. Embryonic stems cells, creating transgenic animals. Methods Cell-Biol 1998; 57: 279-293.
27. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000; 28: 31-40.
28. Lim DA, Tramontin AD, Trevejo JM, Herrera DG, Garcia-Verdugo JM, Alvarez-Buylla A. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron 2000; 28: 713-726.
29. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999; 103: 697-705.
30. van der Horst G, van Bezooijen RL, Deckers MM, Hoogendam J, Visser A, Lowik CW, et al. Differentiation of murine preosteoblastic KS483 cells depends on autocrine bone morphogenetic protein signaling during all phases of osteoblast formation. Bone 2002; 31: 661-669.
31. Gonzalez-Sanchez A, Bader D. Immunochemical analysis of myosin heavy chains in the developing chicken heart. Dev Biol 1984; 103: 151-158.
32. Ikeda Y, Hiroi Y, Hosoda T, Utsunomiya T, Matsuo S, Ito T, et al. Novel point mutation in the cardiac transcription factor CSX/NKX2.5 associated with congenital heart disease. Circ J 2002; 66: 561-563.
33. Tanaka M, Chen Z, Bartunkova S, Yamasaki N, Izumo S. The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 1999; 126: 1269-1280.
34. Molkentin JD, Lin Q, Duncan SA, Olson EN. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev 1997; 11: 1061-1072.
35. Lin Q, Schwarz J, Bucana C, Olson EN. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 1997; 276: 1404-1407.
36. Morkin E. Control of cardiac myosin heavy chain gene expression. Microsc Res Tech 2000; 50: 522-531.
37. Detillieux KA, Sheikh F, Kardami E, Cattini PA. Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 2003; 57: 8-19.
38. Izumi M, Fujio Y, Kunisada K, Negoro S, Tone E, Funamoto M, et al. Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway. J Biol 2001; 276: 31133-31141.
39. Sachinidis A, Gissel C, Nierhoff D, Hippler-Altenburg R, Sauer H, Wartenberg M, et al. Identification of plateled-derived growth factor-BB as cardiogenesis-inducing factor in mouse embryonic stem cells under serum-free conditions. Cell Physiol Biochem 2003; 13: 423-429.
40. Hidaka K, Lee JK, Kim HS, Ihm CH, Iio A, Ogawa M, et al. Chamber-specific differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells. FASEB J 2003; 17: 740-742.
41. Muller M, Fleischmann BK, Selbert S, Ji GJ, Endl E, Middeler G, et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 2000; 14: 2540-2548.
42. Kolossov E, Fleischmann BK, Liu Q, Bloch W, Viatchenko-Karpinski S, Manzke O, et al. Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein. J Cell Biol 1998; 143: 2045-2056.
43. Ortega S, Ittmann M, Tsang SH, Ehrlich M, Basilico C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci USA 1998; 95: 567-5677.